stella
beta
Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease — Stella
Recruiting
Back to Huntington Disease trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(2 sites)
Georgia
Pineo Medical Ecosystem, Tbilisi
Simon Khechinashvili University Hospital, Tbilisi
View full record on ClinicalTrials.gov